The implants have indications to treat de novo spinal infections. Icotec is the first company to earn the FDA’s clearance for stabilizing the spine in infection cases such as discitis, osteomyelitis, pyogenic infection of the intervertebral disc and other spondylopathies.
BlackArmor implants have reduced artifacts from radiolucent carbon/PEEK material, which improves imaging postoperatively.
Along with the FDA nod, CMS approved BlackArmor implants for its New Technology Add-on Payment, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
